dc.contributor.author | Johansen, Silje | |
dc.contributor.author | Kråkenes, Jostein | |
dc.contributor.author | Vedeler, Christian Alexander | |
dc.contributor.author | Storstein, Anette | |
dc.contributor.author | Reikvam, Håkon | |
dc.date.accessioned | 2023-04-03T13:11:54Z | |
dc.date.available | 2023-04-03T13:11:54Z | |
dc.date.created | 2023-02-21T13:06:13Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 2090-6609 | |
dc.identifier.uri | https://hdl.handle.net/11250/3061867 | |
dc.description.abstract | A woman with myelodysplastic syndrome (MDS) was treated with allogeneic hematopoietic stem cell transplantation (allo-HSCT). 65 days after the transplantation, she developed fatigue and central neurological symptoms. Clinical workup including magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) examination revealed findings suspicious for limbic encephalitis (LE), successfully treated with intravenous immunoglobulins and intravenous corticosteroids. Although a rare complication after allo-HSCT, physicians should be aware of neurological symptoms that develop throughout the transplantation course. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Hindawi | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Limbic encephalitis following allogeneic hematopoietic stem cell transplantation | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright 2022 The Author(s) | en_US |
dc.source.articlenumber | 4174755 | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.doi | 10.1155/2022/4174755 | |
dc.identifier.cristin | 2127845 | |
dc.source.journal | Case reports in immunology | en_US |
dc.identifier.citation | Case reports in immunology. 2022, 2022, 4174755 | en_US |
dc.source.volume | 2022 | en_US |